Poster No:
193
Submission Type:
Abstract Submission
Authors:
Rob Colaes1, Gwen Schroyen1, Ahmed Radwan1, Rebeca Alejandra Gavrila Laic1, Sigrid Hatse1, Ann Smeets1, Karen Caeyenberghs2, Stefan Sunaert1, Sabine Deprez1
Institutions:
1KU Leuven, Leuven, Vlaams-Brabant, 2Deakin University, Burwood, Victoria
First Author:
Co-Author(s):
Introduction:
Chemotherapy-induced cognitive impairment's pathophysiology remains unclear. Besides direct neurotoxicity, chemotherapy may trigger peripheral pro-inflammatory responses leading to neuroinflammation and neuronal injury. In this longitudinal study, we assessed changes in pro-inflammatory markers and fixel-based diffusion MRI measures before and after chemotherapy in patients with breast cancer.
Methods:
This longitudinal study included 32 patients receiving chemotherapy for breast cancer (C+), 35 chemotherapy-naïve patients (C-) and 46 healthy women (HC) age- and education matched. Participants were assessed at diagnosis (T0), three months- (T1) and 1-year post-chemotherapy (T2), or at matched intervals. Data collection included multi-shell diffusion-weighted images (voxel=2x2x2mm, TE/TR=85/6400ms, FA=90°, FOV=112x112x66, b=0/200/500/1200/2400/4000, directions=11/20/20/30/61/61, multiband=3), and serum neuroinflammatory markers VILIP-1, MCP-1, sTREM-1, sTREM-2, BDNF, VEG-F, IL-6, IL-18, TNF-ɑ, sRAGE, CX3CL1 and NfL were derived. Image preprocessing was performed using an MRtrix3-based pipeline (Tournier et al., 2019). Multi-tissue constrained spherical deconvolution was used to construct fiber oriented distributions (FOD). A population-based FOD template was constructed, and subject-specific FODs were segmented to estimate fixels and their fiber density (Smith et al., 2013) (Raffelt et al., 2012). Fiber density (FD), fiber cross-section (log-FC), and a combined measure (FDC) were calculated. Linear mixed-effects models were fitted to compare group-differences in each marker over time with HC and T0 as references, including age at T0 as a covariate. Significance was assessed at FDR corrected p<0.05. Group differences in fixel measures were assessed at baseline, T1-T0, and T2-T0 (Genc et al., 2018). Statistical inference was performed using connectivity-based fixel enhancement (Raffelt et al., 2015), with age and intracranial volume as covariates (Smith et al., 2019). Significance was assessed at a FWER corrected p<0.05. Individual linear regression models explored associations between changes in serum markers and fixel measures in regions with significant decreases, reflecting reduced white matter integrity. Significance was assessed at uncorrected p<0.05.
Results:
At T1, C+ patients exhibited significant changes in NfL, BDNF, IL-6, sTREM-1, IL-18, TNF-α, sRAGE, and CX3CL1. At T2, significant changes were observed in NfL, sTREM-1, and CX3CL1 in C+ patients, while C- patients showed significant changes in BDNF, sTREM-1, and CX3CL1. Interaction effects were observed in log-FC in the right superior thalamic radiation and left middle longitudinal fasciculus, but within-group analysis showed no significant changes. In C+ patients, significant decreases at T1 were seen in FD (Nfixels=21, Figure 1A) and FDC (Nfixels=321, Figure 1B) in the left inferior longitudinal fasciculus (ILF), and at T2 in log-FC (Nfixels=68, Figure 1C) in the superior genu of the prefrontal corpus callosum (pfCC). A significant increase in log-FC (Nfixels=36) was observed at T2 in the left ILF. In C- patients, a significant decrease at T2 was found in log-FC (Nfixels=154, Figure 1D) in the posterior genu of the pfCC, and a significant increase in log-FC (Nfixels=64) in the left temporal cingulum. Regression models revealed that decreases between T1-T0 in IL-6, sTREM-1, CX3CL1, and sRAGE were associated with decreases between T2-T0 in log-FC within the pfCC.

Conclusions:
This longitudinal study explored peripheral inflammation as a mechanism in chemotherapy-induced white matter damage. After chemotherapy, C+ patients showed alterations in inflammatory markers and reduced white matter integrity in the left ILF and pfCC. Short-term inflammatory changes were linked to long-term microstructural alterations, suggesting that peripheral inflammation may contribute to chemotherapy-induced white matter damage.
Disorders of the Nervous System:
Neurodegenerative/ Late Life (eg. Parkinson’s, Alzheimer’s) 1
Modeling and Analysis Methods:
Diffusion MRI Modeling and Analysis 2
Keywords:
Blood
Cognition
MRI
Neurological
Toxins
Treatment
White Matter
WHITE MATTER IMAGING - DTI, HARDI, DSI, ETC
Other - Cancer
1|2Indicates the priority used for review
By submitting your proposal, you grant permission for the Organization for Human Brain Mapping (OHBM) to distribute your work in any format, including video, audio print and electronic text through OHBM OnDemand, social media channels, the OHBM website, or other electronic publications and media.
I accept
The Open Science Special Interest Group (OSSIG) is introducing a reproducibility challenge for OHBM 2025. This new initiative aims to enhance the reproducibility of scientific results and foster collaborations between labs. Teams will consist of a “source” party and a “reproducing” party, and will be evaluated on the success of their replication, the openness of the source work, and additional deliverables. Click here for more information.
Propose your OHBM abstract(s) as source work for future OHBM meetings by selecting one of the following options:
I do not want to participate in the reproducibility challenge.
Please indicate below if your study was a "resting state" or "task-activation” study.
Other
Healthy subjects only or patients (note that patient studies may also involve healthy subjects):
Patients
Was this research conducted in the United States?
No
Were any human subjects research approved by the relevant Institutional Review Board or ethics panel?
NOTE: Any human subjects studies without IRB approval will be automatically rejected.
Yes
Were any animal research approved by the relevant IACUC or other animal research panel?
NOTE: Any animal studies without IACUC approval will be automatically rejected.
Not applicable
Please indicate which methods were used in your research:
Diffusion MRI
Other, Please specify
-
Serum markers
For human MRI, what field strength scanner do you use?
3.0T
Which processing packages did you use for your study?
Other, Please list
-
MRtrix3
Provide references using APA citation style.
Genc, S. (2018). Development of white matter fibre density and morphology over childhood: A longitudinal fixel-based analysis. NeuroImage, 183, 666–676.
Raffelt, D. A. (2015). Connectivity-based fixel enhancement: Whole-brain statistical analysis of diffusion MRI measures in the presence of crossing fibres. NeuroImage, 117, 40–55.
Raffelt, D. (2012). Apparent Fibre Density: a novel measure for the analysis of diffusion-weighted magnetic resonance images. NeuroImage, 59(4), 3976–3994.
Smith, R. (2019). On the regression of intracranial volume in Fixel-Based Analysis.
Smith, R. (2013). SIFT: Spherical-deconvolution informed filtering of tractograms. NeuroImage, 67, 298–312.
Tournier, J.-D. (2019). MRtrix3: A fast, flexible and open software framework for medical image processing and visualisation. NeuroImage, 202(116137), 116137.
No